Gül, ÇKürüm, TDemir, MÖzbay, GVural, ÖIqbal, OFareed, J2024-06-122024-06-1220041076-02961938-2723https://doi.org/10.1177/107602960401000114https://hdl.handle.net/20.500.14551/20912Essential thrombocythemia (ET) rarely causes obstruction of coronary arteries or acute myocardial infarction. Treatment of acute myocardial infarction in patients with ET may be a problem due to the important role of platelets in the pathogenesis of infarction. There is no reported case of acute myocardial infarction with essential thrombocythemia treated with a glycoprotein IIb/IIIa inhibitor. In this report, a 49-year-old woman with essential thrombocythemia, admitted with a diagnosis of acute inferolateral myocardial infarction, was treated with tirofiban, a glycoprotein IIb/IIIa receptor blocker.en10.1177/107602960401000114info:eu-repo/semantics/closedAccessEssential ThrombocythemiaGlycoprotein Iib/Iiia Receptor BlockerAcute Myocardial InfarctionTirofibanArticle1017779Q3WOS:0001884386000142-s2.0-214275384614979411Q2